2024

1. A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: the PLATEBRISK study

   EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 20, Núm. 16, pp. 1018-1028

2. Combined Use of MITRACLIP and Ventricular ASSIST Devices in Cardiogenic Shock: MITRA-ASSIST Registry

   Journal of Clinical Medicine, Vol. 13, Núm. 15

3. Early Nonprocedural Bleeding After Left Atrial Appendage Occlusion

   JACC: Cardiovascular Interventions, Vol. 17, Núm. 15, pp. 1765-1776

4. Impact of coronary calcium morphology on intravascular lithotripsy

   EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 20, Núm. 10, pp. e656-e668

5. Impact of gender in patients with device-related thrombosis after left atrial appendage closure – A sub-analysis from the multicenter EUROC-DRT-registry

   Echocardiography, Vol. 41, Núm. 8

6. Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study

   JACC: Cardiovascular Interventions, Vol. 17, Núm. 3, pp. 374-387

7. Impacto del sexo en los tiempos de cateterismo y en el uso de pretratamiento antiagregante plaquetario en pacientes con síndrome coronario agudo sin elevación del segmento ST (SCASEST)

   Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 36, Núm. 2, pp. 123-130

8. Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction

   Clinical Research in Cardiology, Vol. 113, Núm. 8, pp. 1171-1182

9. International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates—2024

   Journal of Heart and Lung Transplantation, Vol. 43, Núm. 10, pp. 1529-1628.e54

10. Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: The ADALA Randomized Clinical Trial

    JAMA Cardiology

11. New technologies for the diagnosis, treatment, and monitoring of cardiovascular diseases

    Revista Espanola de Cardiologia, Vol. 77, Núm. 1, pp. 88-96

12. Patients who suffer a first atherosclerotic cardiovascular event while taking statins are often far off of lipid targets

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 34, Núm. 1, pp. 90-97

13. Practical approach for atrial cardiomyopathy characterization in patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 77, Núm. 8, pp. 656-666

14. Prevalence and prognostic significance of malnutrition in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair

    Catheterization and Cardiovascular Interventions, Vol. 104, Núm. 2, pp. 390-400

15. Prevalence of Fabry disease in patients with left ventricular hypertrophy and renal involvement (PrEFaCe)

    Medicina Clinica

16. Prognosis after heart transplant in patients with hypertrophic and restrictive cardiomyopathy. A nationwide registry analysis

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 304-313

17. Prognostic impact of shock in patients with type A acute aortic syndrome. Results of a nationwide multicenter study

    Hellenic Journal of Cardiology

18. Prognostic impact of vasopressor test in transcatheter edge-to-edge repair of secondary mitral regurgitation: The PETIT study

    Catheterization and Cardiovascular Interventions, Vol. 104, Núm. 2, pp. 378-389

19. Ramipril After Transcatheter Aortic Valve Implantation in Patients Without Reduced Ejection Fraction: The RASTAVI Randomized Clinical Trial

    Journal of the American Heart Association, Vol. 13, Núm. 19, pp. e035460

20. Repetitive ambulatory levosimendan as a bridge to heart transplantation

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 290-301